6. Drugs Acting on Blood: A Complete Guide to Haematinics, Anticoagulants, and Thrombolytics

DRUGS ACTING ON BLOOD AND BLOOD FORMING ORGANS: A TEACHER’S COMPREHENSIVE GUIDE

Welcome, future pharmacists and healthcare professionals!

As a pharmacology educator with years of experience teaching pharmacy students, I have always emphasized that understanding haematological pharmacology is essential for managing some of the most common and life-threatening conditions. The haematologic system is the body’s delivery and defense network—from transporting life-sustaining oxygen to sealing wounds through clotting. Drugs that act on blood are among the most widely prescribed and life-saving medications in clinical practice.

In this comprehensive guide, I will walk you through the major classes of drugs acting on blood and blood-forming organs, including haematinics, anticoagulants, anti-platelet agents, and thrombolytics. We will explore their mechanisms of action, clinical uses, and adverse effects. Let us begin.

Introduction to the Haematologic System

The haematologic system consists of blood and blood-forming organs, including the bone marrow, spleen, and liver. Blood is a specialized body fluid that performs essential functions:

• Transportation: Carries oxygen, nutrients, hormones, and waste products.
• Regulation: Maintains body temperature, pH balance, and fluid balance.
• Protection: Fights infections and seals wounds through clotting.

Drugs acting on this system are used to treat anaemia, prevent and dissolve blood clots, and manage bleeding disorders.

1. Haematinics: The Blood Builders

Haematinics are agents used to treat anaemia—a condition where the blood lacks enough healthy red blood cells (RBCs) or haemoglobin. The three most important haematinics are iron, folic acid, and vitamin B12.

Iron (The Oxygen Carrier)

Iron is the core of haemoglobin, the protein in RBCs that carries oxygen from the lungs to tissues. In iron-deficiency anaemia, the body lacks sufficient iron to produce adequate haemoglobin.

Key Points:

• Daily Requirement: The body needs about 180 mg of elemental iron daily for erythropoiesis, but only about 30% is actually absorbed.
• Pro Tip: Always take iron with Vitamin C (Ascorbic Acid) to significantly boost its bioavailability (up to 3-4 times).
• Common Iron Salts: Ferrous Sulphate (most common), Ferrous Gluconate, and Ferrous Fumarate.
• Side Effects: Gastrointestinal upset, constipation, nausea, dark stools, and epigastric pain.
• Warning: Iron supplements are poisonous to children—keep out of reach and seek immediate help in case of overdose.

Folic Acid (Vitamin B9)

Folic acid is essential for DNA synthesis and cell division. Deficiency leads to Megaloblastic Anaemia, characterized by the production of abnormally large, immature RBCs.

Key Points:

• Sources: Green leafy vegetables, fortified cereals, and liver.
• Importance in Pregnancy: Crucial for preventing neural tube defects (spina bifida) in the developing foetus.
• Clinical Use: Used in megaloblastic anaemia and as a supplement during pregnancy and lactation.

Vitamin B12 (Cyanocobalamin)

Vitamin B12 is stored primarily in the liver. It is vital for mood regulation (serotonin/dopamine synthesis), nerve health, and DNA synthesis.

Key Points:

• Deficiency Causes: Pernicious Anaemia (due to lack of intrinsic factor), strict veganism, and gastrointestinal surgery.
• Signs of Deficiency: Fatigue, numbness/tingling in hands and feet, cognitive impairment, and mood disturbances.
• Treatment: Administered as intramuscular injections (orally in some cases) to restore normal levels.

2. Anti-Coagulants: Preventing New Clots

Anticoagulants inhibit the formation of new blood clots but do not dissolve existing ones. They are used to prevent deep vein thrombosis (DVT), pulmonary embolism, stroke, and heart attacks.

Type	Key Drug	Mechanism of Action
Injectable	Heparin	Binds to anti-thrombin III, inactivating thrombin and factor Xa. Immediate onset; used in hospital settings.
Oral	Warfarin	Vitamin K antagonist; prevents the liver from synthesizing clotting factors (II, VII, IX, X). Requires monitoring (INR).
Oral	Direct Oral Anticoagulants (DOACs)	Examples: Rivaroxaban, Dabigatran. Directly inhibit factor Xa or thrombin. No routine monitoring needed.

Clinical Note: Warfarin therapy requires constant monitoring (International Normalized Ratio, INR) because it can be highly teratogenic (harmful to the foetus) and causes significant drug interactions.

3. Anti-Platelet Agents: Keeping Blood Flowing

Often called “blood thinners” by patients, these drugs stop platelets from sticking together. They are essential for preventing heart attacks (MI) and strokes.

• Aspirin: In low doses (75–300 mg), it irreversibly inhibits platelet aggregation by blocking the COX-1 enzyme. Used for secondary prevention of MI and stroke.
• Clopidogrel: Often used when patients can’t tolerate aspirin or after stent placement (dual anti-platelet therapy with aspirin).
• Dipyridamole: Often combined with aspirin for secondary stroke prevention.
• Ticagrelor: A newer, reversible P2Y12 inhibitor used in acute coronary syndrome.

4. Thrombolytics: The “Clot Busters”

Unlike anticoagulants, thrombolytics are emergency drugs used to dissolve existing, life-threatening clots in the heart, lungs, or brain.

• Alteplase (t-PA): A fibrin-selective agent produced by recombinant DNA technology. It is a first-line treatment for acute ischaemic stroke (within 3-4.5 hours).
• Streptokinase: Derived from bacteria, this is a cost-effective option for treating acute pulmonary embolism and myocardial infarction (MI).
• Tenecteplase: A modified form of t-PA with a longer half-life, allowing single-bolus administration.

Important Warning: Thrombolytics carry a significant risk of bleeding (especially intracranial haemorrhage) and should only be used when the benefits clearly outweigh the risks.

A TEACHER’S PRACTICAL INSIGHTS

Over my years of teaching haematological pharmacology, I have developed a few key insights that I always share with my students:

• “Iron with Vitamin C, Iron without Tea”: Always take iron supplements with Vitamin C for better absorption, but avoid tea and coffee (tannins reduce absorption).
• “Heparin is Fast, Warfarin is Slow”: Heparin works immediately but requires injection. Warfarin takes 3-5 days to become effective but can be taken orally.
• “ASA for Secondary Prevention”: Aspirin is used for secondary prevention (after a heart attack or stroke) rather than primary prevention in low-risk individuals.
• “Time is Brain”: In acute ischaemic stroke, alteplase must be given within 4.5 hours of symptom onset—every minute counts.

Summary

Drugs acting on blood and blood-forming organs are essential for managing anaemia, thrombotic disorders, and bleeding disorders. They include haematinics (iron, folic acid, vitamin B12), anticoagulants (heparin, warfarin, DOACs), anti-platelet agents (aspirin, clopidogrel), and thrombolytics (alteplase, streptokinase).

Understanding their mechanisms of action, clinical uses, adverse effects, and monitoring requirements is essential for safe and rational drug therapy. As a pharmacist, you will encounter these drugs daily—from iron supplements to emergency thrombolysis.

As I always tell my students: “Blood is the river of life—and the drugs that act on it must be understood with precision, respect, and careful monitoring.”

Frequently Asked Questions (FAQs)

1. What are haematinics?

Haematinics are agents used to treat anaemia, including iron, folic acid, and vitamin B12.

2. What is the difference between iron deficiency anaemia and pernicious anaemia?

Iron deficiency anaemia is caused by a lack of iron, while pernicious anaemia is caused by a lack of intrinsic factor needed to absorb vitamin B12.

3. What is the mechanism of action of warfarin?

Warfarin is a Vitamin K antagonist that prevents the liver from synthesizing clotting factors II, VII, IX, and X.

4. What is the antidote for warfarin?

The antidote for warfarin is Vitamin K (phytonadione).

5. What is the mechanism of action of aspirin as an anti-platelet agent?

Aspirin irreversibly inhibits COX-1, preventing the formation of thromboxane A2 and thus inhibiting platelet aggregation.

6. What is the first-line treatment for acute ischaemic stroke?

The first-line treatment for acute ischaemic stroke is Alteplase (t-PA), given within 3-4.5 hours of symptom onset.

7. What is the difference between anticoagulants and thrombolytics?

Anticoagulants prevent the formation of new clots, while thrombolytics dissolve existing clots.

REFERENCES & FURTHER READING

• Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2016). Rang & Dale’s Pharmacology (8th ed.). Elsevier.
• Katzung, B. G., & Vanderah, T. W. (2021). Basic and Clinical Pharmacology (15th ed.). McGraw Hill.
• Goodman, L. S., & Gilman, A. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics (13th ed.). McGraw Hill.
• Sharma, H. L., & Sharma, K. K. (2017). Principles of Pharmacology (3rd ed.). Paras Medical Publisher.
• World Health Organization (WHO). (2022). Haematological and Drug Safety Resources. Retrieved from WHO Official Website.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns.